Edition:
United Kingdom

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

30.78USD
21 Aug 2018
Change (% chg)

$0.88 (+2.94%)
Prev Close
$29.90
Open
$30.00
Day's High
$31.42
Day's Low
$29.79
Volume
19,373
Avg. Vol
7,602
52-wk High
$31.42
52-wk Low
$7.77

Chart for

About

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The... (more)

Overall

Beta: 2.33
Market Cap(Mil.): $12.90
Shares Outstanding(Mil.): 0.74
Dividend: --
Yield (%): --

Financials

  ACER.OQ Industry Sector
P/E (TTM): -- 85.69 32.76
EPS (TTM): -7.59 -- --
ROI: -141.39 1.78 14.61
ROE: -141.39 3.28 16.33

BRIEF-Acer Therapeutics Q4 Loss Per Share $0.63

* ACER THERAPEUTICS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

07 Mar 2018

Competitors

Earnings vs. Estimates